Varex Imaging - VREX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.00
  • Forecasted Upside: 38.52%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$15.16
▼ -0.03 (-0.20%)

This chart shows the closing price for VREX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Varex Imaging Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VREX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VREX

Analyst Price Target is $21.00
▲ +38.52% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Varex Imaging in the last 3 months. The average price target is $21.00, with a high forecast of $21.00 and a low forecast of $21.00. The average price target represents a 38.52% upside from the last price of $15.16.

This chart shows the closing price for VREX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Varex Imaging. This rating has held steady since September 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/23/2024B. RileyInitiated CoverageBuy$21.00
11/15/2023OppenheimerLower TargetOutperform ➝ Outperform$42.00 ➝ $30.00
8/2/2023OppenheimerReiterated RatingOutperform ➝ Outperform$42.00
5/24/2023Jefferies Financial GroupBoost Target$22.00 ➝ $24.00
10/12/2022Jefferies Financial GroupInitiated CoverageHold$24.00
2/5/2021OppenheimerUpgradeMarket Perform ➝ Outperform$41.00
9/29/2020JPMorgan Chase & Co.Lower TargetPositive ➝ Neutral$17.00 ➝ $14.00
8/13/2020OppenheimerDowngradeOutperform ➝ Market Perform
5/13/2020SidotiLower TargetBuy$44.00 ➝ $34.00
5/13/2020Jefferies Financial GroupLower TargetHold$30.00 ➝ $25.00
5/13/2020OppenheimerReiterated RatingBuy$40.00
5/13/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$32.00 ➝ $25.00
3/25/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$32.00
2/12/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$31.00 ➝ $30.00
(Data available from 12/18/2019 forward)

News Sentiment Rating

0.93 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
5/22/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/21/2024
  • 4 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/21/2024
  • 8 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
8/20/2024
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2024
  • 6 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2024
  • 22 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/18/2024

Current Sentiment

  • 22 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Varex Imaging logo
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $15.16
Low: $14.83
High: $15.41

50 Day Range

MA: $14.23
Low: $11.23
High: $16.68

52 Week Range

Now: $15.16
Low: $10.19
High: $21.39

Volume

681,057 shs

Average Volume

509,951 shs

Market Capitalization

$623.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Frequently Asked Questions

What sell-side analysts currently cover shares of Varex Imaging?

The following Wall Street research analysts have issued reports on Varex Imaging in the last year: B. Riley, StockNews.com, and TheStreet.
View the latest analyst ratings for VREX.

What is the current price target for Varex Imaging?

0 Wall Street analysts have set twelve-month price targets for Varex Imaging in the last year. Their average twelve-month price target is $21.00, suggesting a possible upside of 38.5%. B. Riley has the highest price target set, predicting VREX will reach $21.00 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $21.00 for Varex Imaging in the next year.
View the latest price targets for VREX.

What is the current consensus analyst rating for Varex Imaging?

Varex Imaging currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VREX will outperform the market and that investors should add to their positions of Varex Imaging.
View the latest ratings for VREX.

What other companies compete with Varex Imaging?

How do I contact Varex Imaging's investor relations team?

Varex Imaging's physical mailing address is 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT, 84104. The company's listed phone number is (801) 972-5000 and its investor relations email address is [email protected]. The official website for Varex Imaging is www.vareximaging.com. Learn More about contacing Varex Imaging investor relations.